- QMRO Home
- Barts Cancer Institute
- Centre for Experimental Cancer Medicine
- Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma Updated Results From a Phase 1/2 Open-label Study
Browse
Administrators only